摘要
<正>1概况免疫抑制剂是对机体的免疫反应具有抑制作用的药物,抑制免疫反应相关细胞(T细胞、B细胞、巨噬细胞等)的增殖和功能[1],临床上主要用于自身免疫性/炎症性疾病、移植后排异反应和严重过敏反应。常用的免疫抑制剂主要有五类~([1-2]):(1)糖皮质激素类,如可的松和强的松;(2)细胞毒类药物,如硫唑嘌呤、氨甲喋呤、环磷酰胺、霉酚酸酯等;(3)
引文
[1]Wiseman AC.Immunosuppressive medications[J].Clin J Am Soc Nephrol,2016,11(2):332-343.
[2]李晓玉.免疫抑制剂的研究概述[J].药学服务与研究,2015,5(2):105-110.
[3]Kuronuma K,Honda H,Mikami T,et al.Response to pneumococcal vaccine in interstitial lung disease patients:Influence of systemic immunosuppressive treatment[J].Vaccine,2018,36(33):4968-4972.
[4]Kamei K,Miyairi I,Ishikura K,et al.Prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents[J].J Pediatr,2018,196:217-222.
[5]Alten R,Bingham CO 3rd,Cohen SB,et al.Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept[J].BMC Musculoskelet Disord,2016,17:231.
[6]van Assen S,Agmon-Levin N,Elkayam O,et al.EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases[J].Ann Rheum Dis,2011,70(3):414-22.
[7]Bühler S,Eperon G,Ribi C,et al.Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases[J].Swiss Med Wkly,2015,145:w14159.
[8]Papp KA,Haraoui B,Kumar D,et al.Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies[J].J Cutan Med Surg,2019,23(1):50-74.
[9]Papp KA,Haraoui B,Kumar D,et al.Vaccination guidelines for patients with immune-mediated disorders taking immunosuppressive therapies:Executive summary[J].J Rheumatol,2019,[Epub ahead of print]